Characterization of ferroptosis in kidney tubular cell death under diabetic conditions.

Kim S, Kang SW, Joo J, Han SH, Shin H, Nam BY, Park J, Yoo TH, Kim G, Lee P, Park JT. · 2021

Read Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. by Kim S, Kang SW, Joo J, Han SH, Shin H, Nam BY, Park J, Yoo TH, Kim G, Lee P, Park JT. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7870666.txt.

Introduction

Kim and co-authors test whether ferroptosis drives kidney tubule death in diabetes. Diabetic kidney disease is a major harm of diabetes. A growth signal, TGF-β1, helps kill tubule cells. Other death routes were already known there. Ferroptosis is an iron-based death path.

Patient kidney samples showed low levels of two guard genes, xCT and GPX4. In lab cells, the growth signal cut protective glutathione. Fat damage rose at the same time. A ferroptosis blocker eased the cell death. Diabetic mice showed the same guard gene drops in kidney. The authors conclude ferroptosis is a real route of tubule loss. Blocking it may protect diabetic kidneys.

Catalog record

CREATORKim S, Kang SW, Joo J, Han SH, Shin H, Nam BY, Park J, Yoo TH, Kim G, Lee P, Park JT.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7870666

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Characterization of ferroptosis in kidney tubular cell death under diabetic conditions By Seonghun Kim, Shin-Wook Kang, Jeongho Joo, Seung Hyeok Han, Huiyoon Shin, Bo Young Nam, Jimin Park, Tae-Hyun Yoo, Gyuri Kim, Pureunchowon Lee, Jung Tak Park Published in: Cell Death & Disease DOI: 10.1038/s41419-021-03452-x ABSTRACT Abstract Kidney tubular cell death induced by transforming growth factor-β1 (TGF-β1) is known to contribute to diabetic nephropathy, a major complication of diabetes. Caspase-3-dependent apoptosis and caspase-1-dependent pyroptosis are also involved in tubular cell death under diabetic conditions. Recently, ferroptosis, an atypical form of iron-dependent cell death, was reported to cause kidney disease, including acute kidney injury. Ferroptosis is primed by lipid peroxide accumulation through the cystine/glutamate antiporter system Xc− (xCT) and glutathione peroxidase 4 (GPX4)-dependent mechanisms. The aim of this study was to evaluate the role of ferroptosis in diabetes-induced tubular injury. TGF-β1-stimulated proximal tubular epithelial cells and diabetic mice models were used for in vitro and in vivo experiments, respectively. xCT and GPX4 expression, cell viability, glutathione concentration, and lipid peroxidation were quantified to indicate ferroptosis. The effect of ferroptosis inhibition was also assessed. In kidney biopsy samples from diabetic patients, xCT and GPX4 mRNA expression was decreased compared to nondiabetic samples. In TGF-β1-stimulated tubular cells, intracellular glutathione concentration was reduced and lipid peroxidation was enhanced, both of which are related to ferroptosis-related cell death. Ferrostatin-1 (Fer-1), a ferroptosis inhibitor, alleviated TGF-β1-induced ferroptosis. In diabetic mice, kidney mRNA and protein expressions of xCT and GPX4 were reduced compared to control. Kidney glutathione concentration was decreased, while lipid peroxidation was increased in these mice, and these changes were alleviated by Fer-1 treatment. Ferroptosis is involved in kidney tubular cell death under diabetic conditions. Ferroptosis inhibition could be a therapeutic option for diabetic nephropathy. Subject terms: Cell death, Kidney diseases INTRODUCTION Diabetic nephropathy, a severe microvascular complication of diabetes, is characterized by proteinuria and a progressive decline in kidney function, leading to end-stage kidney disease1,2. The pathological features of diabetic nephropathy include extracellular matrix (ECM) accumulation within the glomeruli and tubulointerstitium and glomerular and tubular cell death, all of which contribute to the development of kidney fibrosis and tubular atrophy3–5. Accumulating evidence indicates that high glucose, hemodynamic changes, and local growth factors are all involved in the pathogenesis of diabetic nephropathy6–10. In particular, transforming growth factor-β (TGF-β) is regarded as one of the main mediators of the deleterious effects of the diabetic milieu, and is known to mediate kidney fibrosis and tubular cell death under diabetic conditions11–13. Meanwhile, a number of previous studies have shown that caspase-3-dependent apoptosis and caspase-1-dependent pyroptosis are also involved in tubular cell death in diabetic nephropathy14,15. A new atypical form of cell death, ferroptosis, was recently identified. Ferroptosis, iron-dependent cell death, is different from apoptosis, pyroptosis, and receptor-interacting protein kinase-dependent necroptosis16. The key mediators of ferroptosis are cystine/glutamate antiporter system Xc− (xCT) and glutathione peroxidase 4 (GPX4), an antioxidant enzyme. Low xCT and GPX4 levels reduce intracellular cystine concentrations, which in turn diminish glutathione synthesis, and lipid peroxide degradation, respectively. Both of these changes result in the accumulation of intracellular lipid peroxide, which leads to ferroptosis17–19. Recent studies revealed that ferroptosis is involved in tubular cell death during acute kidney injury (AKI)18,20. Ferrostatin-1 (Fer-1), a small-molecule compound that inhibits lipid oxidation and subsequently suppresses ferroptosis, has been shown to abrogate tubular injury in experimental AKI models21,22. In addition, tubular cell death and interstitial edema within the kidney and proteinuria were significantly increased in GPX4-null mice, suggesting a reno-protective role for GPX4 in tubular cells23. In contrast to AKI, however, the impact of ferroptosis on the development of diabetic nephropathy has not been elucidated. Therefore, the aim of the current study was to investigate the role of ferroptosis in tubular cell death under diabetic conditions. To test our hypothesis, we used TGF-β-stimulated cultured kidney tubular cells and diabetic mice models for in vitro and in vivo experiments, respectively. Furthermore, we also examined the effect of ferroptosis inhibition on diabetes-induced tubular cell injury. MATERIALS AND METHODS Human kidney sample collection Kidney biopsy samples were obtained from 44 adult patients who underwent biopsy procedures due to medical indications at Yonsei Medical Center, Seoul, Korea. Renal biopsy was performed in the standard manner24. Microdissection of the kidney biopsy samples were performed, as previously described25. Kidney tubules, with glomeruli removal through microdissection, was stored in RNAiso reagent at −70 °C (Takara Bio Inc., Otsu, Shiga, Japan). Samples from type 2 diabetic patients whose kidney biopsy pathological diagnosis revealed diabetic nephropathy were allocated as diabetes mellitus (DM). Non-DM samples were from those without DM and whose pathological findings did not show specific abnormalities or only minimal glomerular change. Kidney tissues were collected with the approval from the Institutional Review Board for human research at Yonsei University College of Medicine and informed consent was obtained from all patients (4-2006-0154). Cell culture and treatment of NRK-52E cells NRK-52E cells, immortalized rat proximal tubular epithelial cells, were maintained in DMEM supplemented with 5% fetal bovine serum (FBS), 100 U/ml penicillin, 100 mg/ml streptomycin, and 26 mM NaHCO3, and were grown at 37 °C in humidified 5% CO2 in air. The medium was changed to DMEM containing 5.6 mM glucose 48 h after seeding. Subconfluent NRK-52E cells were FBS-restricted for 24 h, then the medium was replaced with 1% FBS DMEM for the control group and the same medium plus TGF-β1 (10 ng/ml; R&D Systems, Minneapolis, MN, USA) for the TGF-β1 group. Both groups were treated with Fer-1 (1–100 μM; Selleckchem, Houston, TX, USA). NRK-52E cells were harvested 12 h after treatment. Cells were stimulated with Erastin (Selleckchem) for positive control ferroptosis induction. Animal experiments All animal protocols were approved by the Committee for the Care and Use of Laboratory Animals at Yonsei University College of Medicine in Seoul, Korea. All experiments were conducted in accordance with the Principles of Laboratory Animal Care (NIH Publication no. 85-23, revised 1985). Forty C57BL/6 mice weighing 20–25 g were injected with either diluent [n = 20, control (Con)] or 50 mg/kg streptozotocin (STZ; Sigma-Aldrich, St. Louis, MO, USA; n = 20, STZ) intraperitoneally for five consecutive days. Tail vein blood glucose levels were measured to confirm DM (fasting blood glucose > 300 mg/dl). Ten mice from each group were treated with Fer-1 (5 mg/kg/day) via Alzet osmotic pumps (DURECT Corporation, Cupertino, CA, USA). Mice were housed in a temperature-controlled room and given free access to water and standard laboratory chow during the 12-week study period. After 12 weeks, mice were anesthetized with Zoletil (10 mg/kg; Virbac, Carros, France), and kidneys were extracted after sacrifice. Body weight, kidney weight, blood glucose, blood urea nitrogen (BUN), serum creatinine, 24-h urinary albumin, and creatinine concentrations were determined at the time of sacrifice. Blood glucose was measured with a glucometer, and 24-h urinary albumin was assessed via enzyme-linked immunosorbent assay (ELISA; Nephrat II, Exocell Inc., Philadelphia, PA, USA). BUN, serum creatinine, and 24-h urinary creatinine were analyzed using a Cobas 8000 C702 (Roche, Mannheim, Baden Württemberg, Germany). Type 2 DM db/db mice and genetic control non-DM db/m mice (6 weeks old, three per group) were obtained from Jackson Laboratories (Bar Harbor, ME, USA) and were sacrificed after 12 weeks. Quantitative real-time polymerase chain reaction Total RNA

Read the complete text